American National Insurance’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $3.56M | Sell |
68,675
-11,270
| -14% | -$585K | 0.96% | 19 |
|
|
2021
Q4 | $4.72M | Sell |
79,945
-377,642
| -83% | -$18.7M | 1.05% | 17 |
|
|
2021
Q3 | $19.7M | Sell |
457,587
-350
| -0.1% | -$15.5K | 0.74% | 26 |
|
|
2021
Q2 | $17.9M | Sell |
457,937
-610
| -0.1% | -$23.7K | 0.67% | 29 |
|
|
2021
Q1 | $16.6M | Sell |
458,547
-40
| -0% | -$1.42K | 0.68% | 30 |
|
|
2020
Q4 | $16.9M | Sell |
458,587
-24,764
| -5% | -$908K | 0.72% | 27 |
|
|
2020
Q3 | $16.8M | Hold |
483,351
| – | – | 0.81% | 25 |
|
|
2020
Q2 | $15M | Buy |
483,351
+14,203
| +3% | +$483K | 0.78% | 31 |
|
|
2020
Q1 | $14.5M | Hold |
469,148
| – | – | 0.94% | 22 |
|
|
2019
Q4 | $17.4M | Sell |
469,148
-45,723
| -9% | -$1.63M | 0.91% | 25 |
|
|
2019
Q3 | $17.6M | Hold |
514,871
| – | – | 0.93% | 29 |
|
|
2019
Q2 | $21.2M | Hold |
514,871
| – | – | 1.13% | 14 |
|
|
2019
Q1 | $20.7M | Hold |
514,871
| – | – | 1.09% | 17 |
|
|
2018
Q4 | $21.3M | Hold |
514,871
| – | – | 1.25% | 13 |
|
|
2018
Q3 | $21.5M | Sell |
514,871
-68,269
| -12% | -$2.63M | 1.06% | 16 |
|
|
2018
Q2 | $20.1M | Hold |
583,140
| – | – | 0.99% | 16 |
|
|
2018
Q1 | $19.6M | Hold |
583,140
| – | – | 1% | 19 |
|
|
2017
Q4 | $20M | Hold |
583,140
| – | – | 1.01% | 20 |
|
|
2017
Q3 | $19.8M | Hold |
583,140
| – | – | 1.04% | 19 |
|
|
2017
Q2 | $18.6M | Hold |
583,140
| – | – | 1.01% | 23 |
|
|
2017
Q1 | $18.9M | Hold |
583,140
| – | – | 1.05% | 22 |
|
|
2016
Q4 | $18M | Hold |
583,140
| – | – | 1.04% | 22 |
|
|
2016
Q3 | $18.7M | Hold |
583,140
| – | – | 1.09% | 16 |
|
|
2016
Q2 | $19.5M | Hold |
583,140
| – | – | 1.14% | 13 |
|
|
2016
Q1 | $16.4M | Sell |
583,140
-1,434
| -0.2% | -$41K | 0.98% | 22 |
|
|
2015
Q4 | $17.9M | Hold |
584,574
| – | – | 1.06% | 20 |
|
|
2015
Q3 | $17.4M | Hold |
584,574
| – | – | 1.11% | 15 |
|
|
2015
Q2 | $18.6M | Hold |
584,574
| – | – | 1.1% | 14 |
|
|
2015
Q1 | $19.3M | Hold |
584,574
| – | – | 1.14% | 15 |
|
|
2014
Q4 | $17.3M | Hold |
584,574
| – | – | 1.03% | 15 |
|
|
2014
Q3 | $16.4M | Hold |
584,574
| – | – | 1% | 16 |
|
|
2014
Q2 | $16.5M | Hold |
584,574
| – | – | 1% | 15 |
|
|
2014
Q1 | $17.8M | Hold |
584,574
| – | – | 1.14% | 13 |
|
|
2013
Q4 | $17M | Hold |
584,574
| – | – | 1.1% | 14 |
|
|
2013
Q3 | $15.9M | Hold |
584,574
| – | – | 1.14% | 13 |
|
|
2013
Q2 | $15.5M | Buy |
+584,574
| New | +$16.2M | 1.16% | 11 |
|
Other funds holding PFE
American National Insurance's PFE Position: Q1 2022 in Review
American National Insurance reduced its Pfizer (PFE) stake by 14% in Q1 2022, selling an estimated $585K and leaving 68,675 shares worth $3.56M. The position accounts for 0.96% of the portfolio, ranked #19.
American National Insurance first reported a position in PFE in Q2 2013 and has held it in 36 quarters since. The position peaked at $21.5M in Q3 2018. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.
- American National Insurance held 68,675 shares of Pfizer worth $3.56M as of Q1 2022.
- American National Insurance sold 11,270 Pfizer shares in Q1 2022, an estimated $585K.
- Pfizer made up 0.96% of American National Insurance's portfolio in Q1 2022, its #19 holding.
- American National Insurance first reported a position in Pfizer in Q2 2013 and has held it in 36 quarters since.
- American National Insurance's Pfizer position peaked at $21.5M in Q3 2018.
- 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.
Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.